
- Pharmaceutical Technology-01-02-2019
- Volume 43
- Issue 1
Evaluating a New Quality Control Test for Soft Gelatin Rectal Capsules
This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.
Soft gelatin capsules (SGC) are popularly used pharmaceutical dosage forms, whose critical quality attributes are efficient opening/rupture, disintegration, and dissolution. Unlike oral capsules, however, rectal capsules must dissolve in minimal fluid and hydrodynamics, without digestive enzymes to break down the crosslinking of gelatin if any. Therefore, a reliable biomimetic method is needed to characterize SGC rupture/disintegration during rectal administration. This article demonstrates how qualitative physical attributes testing, a method that has recently been approved for use by the World Health Organization, can be used to achieve these goals.
Please click
for a PDF of the article.
Peer-Reviewed
Submitted: Sept. 4, 2018
Accepted: Oct. 16, 2018
About the author
Yasvanth Ashokraj*, yasvanth.ashokraj@cipla.com, Swati Laud, Kalpesh Sawant, Prashant Modak, and Praveen Date all work in Integrated Product Development at CIPLA.
*To whom all correspondence should be addressed.
Article Details
Pharmaceutical Technology
Vol. 43, No. 1
January 2019
Pages: 41–45
Citation
When referring to this article, please cite it as Y. Ashokraj et al., “Evaluating a New Quality Control Test for Soft Gelatin Rectal Capsules,” Pharmaceutical Technology 43 (1) 2019.
Articles in this issue
almost 7 years ago
Packaging Peril: ‘No-Deal’ Brexit May Lead to Missed Deadlineabout 7 years ago
Looking Beyond the Deadlineabout 7 years ago
Great Expectationsabout 7 years ago
Smarter Packaging Comes to the Pharma Marketabout 7 years ago
Improved Mixer Lift and Seal Designsabout 7 years ago
Tabletop Spray Dryerabout 7 years ago
Microplate Spectrophotometerabout 7 years ago
Electrical Position Indicator for Linear Actuatorsabout 7 years ago
FDA Marks Record Year for New Drug ApprovalsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




